Molecular and immunologic markers of kidney cancer—potential applications in predictive, preventive and personalized medicine

Kidney cancer is one of the deadliest malignancies due to frequent late diagnosis (33 % or renal cell carcinoma are metastatic at diagnosis) and poor treatment options. There are two major subtypes of kidney cancer: renal cell carcinoma (RCC) and renal pelvis carcinoma. The risk factors for RCC, acc...

Descripción completa

Detalles Bibliográficos
Autores principales: Mickley, Amanda, Kovaleva, Olga, Kzhyshkowska, Julia, Gratchev, Alexei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4617448/
https://www.ncbi.nlm.nih.gov/pubmed/26500709
http://dx.doi.org/10.1186/s13167-015-0042-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4617448/
https://www.ncbi.nlm.nih.gov/pubmed/26500709
http://dx.doi.org/10.1186/s13167-015-0042-2

Ejemplares similares